Scenesse is a medicine that can give sufferers of Erythropoietic Protoporphyria (EPP) a new lease on life. The FDA approval of Scenesse for EPP in October 2019 was a watershed moment for US patients with this devastating disease. It has been a long time coming and it is now ready for use. The path to insurance approval is long and arduous but doable. Because it was just approved by the FDA, it will require a lot of flips and twists to get it to the patients who need it. The path starts by establishing your account with Klara, by going to this link. You will then contact us to set up your EPP consultation. A small silver lining to the Corona Virus epidemic has made it easier for us to help patients who do not live in Florida or Louisiana, where Dr Resnik is licensed. Please understand that Scenesse is not yet approved and therefore not available for patients with Vitiligo, Polymorphous Light Eruption and other photosensitive diseases. We will constantly update our Blog, Facebook and Instagram accounts as we get new information.
Scenesse for EPP is ready for Prime Time
Love this Post? Spread the World